The figures show that ADHD medicine prescriptions have seen the steepest rise, particularly since 2020/21. Last year, 278,000 ...

AZ said adding YS2302018 to its pipeline strengthens its cardiovascular portfolio with a drug that could have potential in a ...

UK Health Secretary Wes Streeting has announced plans to allow NHS England to share primary care data with scientific ...

The week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma group ...

The phase 3b BATURA study showed Airsupra (albuterol/budesonide) achieved a statistically significant reduction in the risk of severe asthma exacerbations when used as needed for rescue therapy ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli ...

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and ...

In 2023, BMS received a similar approval across the pond. The National Institute for Health and Care Excellence (NICE) ...

HALIX, a Dutch contract development and manufacturing organisation (CDMO) specialising in complex therapeutic antibodies and ...

Starting January 1, 2025, most Blue Shield commercial members using Fresenius Kabi's adalimumab-aacf (a Humira biosimilar) ...

In the third, final, and by most reckonings most inconsequential, national debate of the US presidential election, vice ...